ATI RN
ATI Pharmacology 2023 Questions
Extract:
Question 1 of 5
A nurse is caring for a client who develops an anaphylactic reaction to IV antibiotic administration. After assessing the client's respiratory status and stopping the medication infusion. Which of the following actions should the nurse take next?
Correct Answer: A
Rationale:
Correct Answer: A: Administer epinephrine 1M.
Rationale: Epinephrine is the first-line treatment for anaphylaxis as it helps to reverse the severe allergic reaction by constricting blood vessels, increasing heart rate, and opening airways, thus improving breathing and blood pressure. Administering epinephrine intramuscularly is recommended in the initial management of anaphylaxis.
Summary of other choices:
B: Replacing the IV infusion with saline may help maintain fluid status but does not address the anaphylactic reaction.
C: Diphenhydramine may be used to relieve itching and hives but does not address the life-threatening respiratory distress in anaphylaxis.
D: Elevating the legs and feet does not address the immediate need to treat the anaphylactic reaction and may delay necessary interventions.
Question 2 of 5
A nurse is preparing to administer a medication to a client for the first time and needs to know about potential food and medication interactions. Which of the following actions should the nurse take?
Correct Answer: B
Rationale:
Correct Answer: B
Rationale:
1. Consulting a drug reference guide is essential to gather information on potential food and medication interactions.
2. Drug reference guides provide comprehensive and up-to-date information on drug interactions.
3. It is a reliable source to ensure the safety and effectiveness of medication administration.
4. This proactive approach demonstrates thorough research and professional responsibility.
Incorrect
Choices:
A: Having the client take the medication on an empty stomach may not always be the appropriate action and could lead to adverse effects.
C: Relying on another nurse's knowledge may not guarantee accurate information on all potential interactions.
D: Checking the client's medical record may provide some information, but a drug reference guide offers more extensive details on interactions.
Question 3 of 5
A nurse is assessing a client who has started taking theophylline. Which of the following client findings should indicate to the nurse that the medication is effective?
Correct Answer: B
Rationale: The correct answer is B: Decreased wheezing. Theophylline is a bronchodilator used to treat respiratory conditions like asthma by relaxing the muscles in the airways. When theophylline is effective, it helps to open up the airways, leading to decreased wheezing. This indicates improved airflow and better respiratory function. Increased blood pressure (
A) is not a direct indication of theophylline effectiveness. Decreased urine output (
C) could suggest dehydration or kidney issues, not necessarily related to theophylline. Increased level of consciousness (
D) is a general assessment parameter and not specific to theophylline effectiveness.
Question 4 of 5
A nurse is preparing to administer filgrastim 5 mcg/kg/day subcutaneous to a client who weighs 143 lb. How many mcg should the nurse administer per day? (Round the answer to the nearest whole number. Use a leading zero if it applies. Do not use a trailing zero.)
Correct Answer: A
Rationale:
To calculate the dose of filgrastim for the client, first convert the weight from pounds to kilograms. 143 lb / 2.2 = 65 kg.
Then, multiply the weight in kg by the dosage of 5 mcg/kg/day. 65 kg * 5 mcg/kg/day = 325 mcg/day.
Therefore, the correct answer is A: 325 mcg/day.
Choices B, C, and D are incorrect because they do not accurately calculate the dose based on the client's weight and the prescribed dosage.
Question 5 of 5
A nurse is reviewing the laboratory data of a client who is receiving filgrastim. Which of the following laboratory values should the nurse monitor to evaluate the effectiveness of the treatment?
Correct Answer: D
Rationale: The correct answer is D: WBC count. Filgrastim is a medication that stimulates the production of white blood cells (WBCs). Monitoring the WBC count is essential to evaluate the effectiveness of the treatment as an increase in WBC count indicates that the medication is working to boost the immune system.
A: Potassium level is not directly related to filgrastim therapy.
B: BUN (blood urea nitrogen) is not typically affected by filgrastim.
C: INR (International Normalized Ratio) is a measure of blood clotting and is not relevant to monitoring filgrastim therapy.
Therefore, the correct choice is D as it directly reflects the intended therapeutic effect of filgrastim.